Trials / Sponsors / Jason J. Luke, MD
Jason J. Luke, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors Advanced Solid Tumor, IDH1 Mutation, Glioma | Phase 2 | 2021-09-20 |
| Terminated | Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Wit Melanoma | Phase 1 / Phase 2 | 2021-05-28 |